학술논문
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Document Type
Article
Author
Coleman, Robert L; Brady, Mark F; Herzog, Thomas J; Sabbatini, Paul; Armstrong, Deborah K; Walker, Joan L; Kim, Byoung-Gie; Fujiwara, Keiichi; Tewari, Krishnansu S; O'Malley, David M; Davidson, Susan A; Rubin, Stephen C; DiSilvestro, Paul; Basen-Engquist, Karen; Huang, Helen; Chan, John K; Spirtos, Nick M; Ashfaq, Raheela; Mannel, Robert S
Source
In The Lancet Oncology June 2017 18(6):779-791
Subject
Language
ISSN
1470-2045